The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index. The fund invests at least 80% of its net assets in financial instruments and securities of the index, ETFs that track the index and other financial instru... The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index. The fund invests at least 80% of its net assets in financial instruments and securities of the index, ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index includes domestic companies from the healthcare sector, which includes the following industries: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified. Show more
Amsterdam, The Netherlands, and Holzgerlingen, Germany, July 01, 2020, 08:30 am CEST - Curetis N.V. in liquidatie (the "Company") today announced the publication of its audited 2019 full year...
Amsterdam, The Netherlands, and Holzgerlingen, Germany, April 30, 2020, 08:00 am CET - Curetis N.V. in liquidatie (the "Company") today announced that the publication of its audited 2019 full...
Amsterdam, the Netherlands, Holzgerlingen, Germany April 20, 2020, 8:00 am CEST - Curetis N.V. in liquidatie (the "Company") announces that the liquidators of the Company have resolved upon a...
- Following approval of shareholders, companies sign German transfer agreement - Curetis GmbH and its subsidiaries Curetis USA Inc. and Ares Genetics GmbH are now wholly owned by OpGen, Inc...
Vote approving transaction passes with 95% support for the transaction Closing expected in the coming days GAITHERSBURG, Md., March 30, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN...
Quorum achieved for OpGen stockholder vote on Curetis business combination with 99% of votes supporting transactionTransaction close anticipated by early April 2020Combined OpGen and Curetis...
Shareholder proxy vote achieves quorum with 99% support for the transaction Final step in OpGen / Curetis business combination achieved pending results of Special Meeting GAITHERSBURG, Md...
GAITHERSBURG, Md., March 19, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help...
, a developer of next-level molecular diagnostic solutions, today announced that it starts offering a CE-IVD certified real-time PCR test kit for SARS-CoV2 (also known as 2019-nCov), the causal...
Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, March 10, 2020, 16:15 pm CET - Curetis N.V. (the "Company" and together with its subsidiaries "Curetis"), a developer...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 11.45 | 11.3198220465 | 101.15 | 112.59 | 100.55 | 52366 | 107.17766625 | SP |
4 | 0.09 | 0.0799928895209 | 112.51 | 123.1411 | 98.25 | 52771 | 110.52713555 | SP |
12 | -28.02 | -19.9260418148 | 140.62 | 142.1 | 98.25 | 33366 | 119.82400771 | SP |
26 | -1.15 | -1.01098901099 | 113.75 | 143.51 | 98.25 | 33448 | 120.73023928 | SP |
52 | 22.35 | 24.7645429363 | 90.25 | 143.51 | 87.63 | 36111 | 115.58461404 | SP |
156 | -8.61 | -7.10337430905 | 121.21 | 149.575 | 75.39 | 59641 | 109.65987537 | SP |
260 | 45.62 | 68.1098835473 | 66.98 | 149.575 | 23.5483 | 79318 | 88.3087586 | SP |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales